PEPG Projected Dividend Yield
PepGen Incorporation ( NASDAQ : PEPG )PepGen Inc. is a clinical-stage biotechnology company. Co. is engaged in advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. Its proprietary enhanced delivery oligonucleotide (EDO), platform leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake and nuclear delivery. Using these EDO peptides, the Co. is generating a pipeline of oligonucleotide therapeutic candidates that are designed to target the root cause of serious diseases. 21 YEAR PERFORMANCE RESULTS |
PEPG Dividend History Detail PEPG Dividend News PEPG Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |